While advances in medicine, technology and healthcare services offer promises of longevity
and improved quality of life (QoL), there is also increasing reliance on a patient׳s skills and …

Alemtuzumab (Lemtrada™) is a humanized monoclonal antibody approved in more than 50
countries. Within the European Union, alemtuzumab is indicated for the treatment of adult …

Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple
sclerosis and 24,091 healthy controls for 161,311 autosomal variants and identified 135 …

Background Glatiramer acetate, approved for the treatment of relapsing-remitting multiple
sclerosis, reduces relapses and disease activity and burden monitored by MRI. We assessed …

Despite high‐dose intravenous immunoglobulin (IVIG) is widely used in treatment of a
number of immune‐mediated neurological diseases, the consensus on its optimal use is …

Objectives To study the safety and efficacy of vitamin D3 as an add on therapy to interferon β-1b
(IFNB) in patients with multiple sclerosis (MS). Methods 1 year, double blind, placebo …

Introduction Stuttering may have a holistic effect on the quality of life of a person who stutters
by limiting participation in social situations, resulting in feelings of isolation and frustration, …

Background Although several disease-modifying treatments are available for relapsing multiple
sclerosis, treatment effects have been more modest in progressive multiple sclerosis and …

Objective: To relate the expression of HIV regulatory proteins and HIV-specific mRNA in the
brain cells of infected individuals with clinical neurological disease. Design: Formalin-fixed …

Genetic risk for multiple sclerosis (MS) is thought to involve both common and rare risk alleles.
Recent GWAS and subsequent meta-analysis have established the critical role of the HLA …